Clinical Trials Logo

Urinary Tract Infection clinical trials

View clinical trials related to Urinary Tract Infection.

Filter by:

NCT ID: NCT00305227 Completed - Clinical trials for Urinary Tract Infection

Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection

Start date: March 2006
Phase: Phase 2
Study type: Interventional

Recurrent urinary tract infections (RUTIS) continue to be a major health problem in women and are now complicated by increasing antibiotic resistance. New preventive approaches are needed. Because most women with RUTI lack the normal protective Lactobacillus (LB) in their vaginal flora, we hypothesized that restoration of LB would reduce RUTIS. In this trail, women with recent UTI are randomized to receive either LB or placebo vaginal capsules and are followed for side effects, for colonization with LB and for occurrence of RUTI over hte next four months.

NCT ID: NCT00200616 Completed - Clinical trials for Urinary Tract Infection

Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.

Start date: April 2001
Phase: N/A
Study type: Interventional

Randomized, prospective, multicenter study in order to assess the usefulness of antimicrobial prophylaxis in children with isolated vesico-ureteral reflux (grade III or less).

NCT ID: NCT00194532 Completed - Clinical trials for Urinary Tract Infection

Cefpodoxime vs Ciprofloxacin for Acute Cystitis

Start date: June 2005
Phase: N/A
Study type: Interventional

Urinary tract infection (UTI) is a very common problem in young healthy women, afflicting approximately one-half of women by their late 20s. One of the most common antibiotics used to treat UTIs is ciprofloxacin, usually for a total of three days. However, increasing resistance to this antibiotic has raised concerns about its overuse for cystitis and generated interest in alternative agents. An alternative antibiotic which is approved for use in UTIs is cefpodoxime. However, there are few studies evaluating the efficacy and tolerance of this compound when given in a 3-day regimen as is commonly used for treatment of UTI. The major purpose of this study is to assess the efficacy and tolerance of a 3-day regimen of cefpodoxime versus ciprofloxacin for treatment of acute uncomplicated cystitis.

NCT ID: NCT00192738 Completed - Pneumonia Clinical Trials

Does Telephone Follow-up Improve Patients Satisfaction

Start date: April 2003
Phase: N/A
Study type: Observational

Several studies have shown the importance of Telephone follow-up in reducing hospital readmissions for heart failure. Therefore, we aimed in this cohort to investigate whether telephone follow-up with patients discharged from the general internal department improves patients' satisfaction, increases compliance to treatment and reduces adverse effects. Patients are recruited from the department of general internal medicine who gave informed consent and could communicate. Patients are interviewed by during hospital stay, one and three months later. This group will be compared with patients that are not interviewd by phone aftert hospital discharge.

NCT ID: NCT00142064 Completed - Kidney Diseases Clinical Trials

A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures

Start date: August 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if a single application of Lidocaine gel topical anesthesia is as effective in decreasing the discomfort associated with urinary catheterization as two applications, within our pediatric population. Currently, two applications is our standard of care within our pediatric Radiology Department. Urinary catheterization is the process of placing a flexible tube into the urinary opening (urethra), to drain urine or instill radiographic solution for study of the anatomy and/or function of the urinary system. Members of the study team hypothesize equivalence in the observer reported catheterization pain scores as measured by the FLACC pain scale. The study is designed to obtain conclusive data to guide clinical practice. The study team hypothesizes that statistically similar levels of analgesia will be observed with the single application procedure as compared to the multiple application technique.

NCT ID: NCT00130221 Completed - Sepsis Clinical Trials

Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections

Start date: June 2005
Phase: Phase 1
Study type: Interventional

Patients in the intensive care unit are at risk for many infections because the severity of illness and the procedures necessary to care for them. This study is designed to look at a change in bathing procedure as a method to reduce infections. Currently, patients at John H. Stroger Hospital are cleansed with soap and water. However, preliminary data from a previous study at Rush University Medical Center showed that a chlorhexidine (CHG)-impregnated cloth (2% CHG Antiseptic Cloth system, Sage Products, Inc.) decreased skin bacteria and may lessen bacteria in the blood stream. The 2% CHG Antiseptic Cloth system is a non-irritating, no-rinse, cleansing and moisturizing product that contains 2% chlorhexidine gluconate. The goal of this proposed study is to further evaluate the effectiveness of the 2% CHG Antiseptic Cloth system compared with soap and water in cleansing the skin and preventing bacteria from entering the bloodstream.

NCT ID: NCT00126698 Completed - Clinical trials for Urinary Tract Infection

Prophylactic Antibiotics on Urethral Catheter Withdrawal

Start date: January 2005
Phase: Phase 4
Study type: Interventional

Urinary-tract infection (UTI) is the most common type of hospital-acquired infection (30% of all). The purpose of this study is to determine whether antibiotic prophylaxis for urinary catheter removal is useful at preventing catheter-associated urinary-tract infection.

NCT ID: NCT00121797 Recruiting - Clinical trials for Urinary Tract Infection

Peripartum Bacteruria and Urinary Tract Infections (UTI)

Start date: January 2004
Phase: N/A
Study type: Interventional

In the last years urinary tract infections (UTI) and pyelonephritis have been the most common reason for readmission to our hospital after birth. UTI is know to be one of the leading causes of postpartum fever affecting about 3%-8% of all postpartum women. The investigators hypothesize that collecting urine cultures pre- and postnatally may help identify women at risk for developing UTI, while treating women with positive cultures could decrease the rehospitalization rate due to postpartum fever. Collecting data during delivery may help identify women at risk for this complication.

NCT ID: NCT00100061 Active, not recruiting - Clinical trials for Urinary Tract Infection

Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the role of cranberry-containing products in preventing urinary tract infections (UTIs).

NCT ID: NCT00093938 Completed - Clinical trials for Urinary Tract Infection

Cranberry Juice for Preventing Bacteria in Urine During Pregnancy

Start date: December 2004
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the amount of cranberry juice that is most effective in preventing a condition in pregnant women that often leads to urinary tract infections (UTIs).